Albemarle Corporation
General ticker "ALB" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $14.8B (TTM average)
Albemarle Corporation follows the US Stock Market performance with the rate: 39.5%.
Estimated limits based on current volatility of 1.6%: low 114.69$, high 118.32$
Factors to consider:
- Earnings expected soon, date: 2026-08-05 amc
- Company included in S&P500 list
- Company pays dividends (irregularly): last record date 2026-06-12, amount 0.41$ (Y0.35%)
- Total employees count: 7800 (-6.0%) as of 2025
- China accounted for 36.5% of revenue in the fiscal year ended 2024-12-31
- US accounted for 16.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Raw material costs, Battery tech shift, Project execution risks, Safety incidents
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [103.41$, 179.58$]
- 2026-12-31 to 2027-12-31 estimated range: [84.72$, 152.35$]
Financial Metrics affecting the ALB estimates:
- Negative: with PPE of -184.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Positive: 6.73 < Operating cash flow per share per price, % of 7.49
- Positive: 42.34 < Shareholder equity ratio, % of 58.22 <= 63.79
- Positive: -9.07 < Industry operating profit margin (median), % of 1.15
- Positive: Inventory ratio change, % of -4.38 <= -0.76
- Positive: Interest expense per share per price, % of 1.21 <= 3.33
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.27
Short-term ALB quotes
Long-term ALB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $9,688.39MM | $5,377.53MM | $5,142.73MM |
| Operating Expenses | $9,436.51MM | $7,154.07MM | $5,509.82MM |
| Operating Income | $251.88MM | $-1,776.55MM | $-367.08MM |
| Non-Operating Income | $-5.14MM | $12.72MM | $-184.99MM |
| Interest Expense | $116.07MM | $165.62MM | $207.65MM |
| R&D Expense | $85.72MM | $86.72MM | $51.40MM |
| Income(Loss) | $246.74MM | $-1,763.83MM | $-552.07MM |
| Taxes | $430.28MM | $87.08MM | $156.88MM |
| Other Income(Loss) | $1,854.08MM | $715.43MM | $243.74MM |
| Net Income(Loss)* | $1,573.48MM | $-1,179.45MM | $-510.63MM |
| Stockholders Equity | $9,412.18MM | $9,961.52MM | $9,533.36MM |
| Inventory | $2,161.29MM | $1,502.53MM | $1,179.27MM |
| Assets | $18,270.65MM | $16,609.65MM | $16,374.21MM |
| Operating Cash Flow | $1,326.58MM | $687.88MM | $1,282.27MM |
| Capital expenditure | $2,154.54MM | $1,680.53MM | $589.80MM |
| Investing Cash Flow | $-2,564.57MM | $-1,584.77MM | $-146.01MM |
| Financing Cash Flow | $623.91MM | $1,241.73MM | $-834.19MM |
| Earnings Per Share** | $13.41 | $-10.04 | $-4.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.